Home | MyCME | All CME | Blog | Psychlopedia

CME Activities From Our Journals

Online CME Activities

+JCP CME Activities [Series Home Page]

Liu et al

JCP CME

Depression and Anxiety in the Postpartum Period and Risk of Bipolar Disorder: A Danish Nationwide Register-Based Cohort Study

Xiaoqin Liu, Esben Agerbo, Jiong Li, Samantha Meltzer-Brody, Veerle Bergink, and Trine Munk-Olsen

Activity | Posttest | Credits: 1.00 | Expires: 5/31/2019 | Keywords: depression, bipolar disorder, anxiety

Consistent evidence has correlated postpartum psychosis with later conversion to bipolar disorder, but nonpsychotic affective disorders are more common in the postpartum period. Could these less severe episodes following childbirth also be markers of underlying bipolar disorder? Read this journal CME research article to learn more.

Maust et al

JCP CME

National Trends in Antidepressant, Benzodiazepine, and Other Sedative-Hypnotic Treatment of Older Adults in Psychiatric and Primary Care

Donovan T. Maust, Frederic C. Blow, Ilse R. Wiechers, Helen C. Kales, and Steven C. Marcus

Activity | Posttest | Credits: 1.00 | Expires: 4/30/2019 | Keywords: depression, anxiety, insomnia, dementia

When you see older patients, do you verify the appropriateness of their prescribed psychotropic drugs? Prescriptions of antidepressants, benzodiazepines, and sedative-hypnotics have increased in this population, even among patients with no mental health diagnosis. Read this journal CME article comparing trends in psychiatry versus primary care.

Epperson et al

JCP CME

Adverse Childhood Experiences and Risk for First-Episode Major Depression During the Menopause Transition

Cynthia Neill Epperson, Mary D. Sammel, Tracy L. Bale, Deborah R. Kim, Sarah Conlin, Stephanie Scalice, Katharine Freeman, and Ellen W. Freeman

Activity | Posttest | Credits: 1.00 | Expires: 3/31/2019 | Keyword: depression

The risk of a first episode of depression increases during perimenopause and early postmenopause. What is the role of childhood adversity in the onset of major depressive disorder during the menopause transition? Read this journal CME article to learn about new research results.

Zimmerman et al

JCP CME

Identifying Remission From Depression on 3 Self-Report Scales

Mark Zimmerman, Emily Walsh, Michael Friedman, Daniela A. Boerescu, and Naureen Attiullah

Activity | Posttest | Credits: 1.00 | Expires: 2/28/2019 | Keyword: depression

Experts in the treatment of depression have emphasized the importance of striving for remission. But how do you know when your patient's depression has remitted? Do different standardized scales find similar results? Learn more in this CME article by Zimmerman and coworkers.

Liperoti et al

JCP CME

Antipsychotic Drug Interactions and Mortality Among Nursing Home Residents With Cognitive Impairment

Rosa Liperoti, Federica Sganga, Francesco Landi, Eva Topinkova, Michael D. Denkinger, Henriëtte G. van der Roest, Andrea D. Foebel, Harriet Finne-Soveri, Roberto Bernabei, and Graziano Onder

Activity | Posttest | Credits: 1.00 | Expires: 1/31/2019 | Keywords: dementia, Alzheimer's, medical conditions

Elderly individuals often take multiple medications each day. Age-related changes in pharmacodynamics and pharmacokinetics make this population particularly susceptible to adverse events related to drug interactions. Read this journal CME article to learn about safety issues with antipsychotic medications in these patients.

Marengoni et al

JCP CME

Adherence to Selective Serotonin and Serotonin-Norepinephrine Reuptake Inhibitor Prescriptions Affects Overall Medication Adherence in Older Persons: Evidence From the Italian Nationwide OsMed Health-DB Database

Alessandra Marengoni, Graziano Onder, Luca Degli Esposti, Pierluigi Russo, Diego Sangiorgi, Stefano Buda, Massimo Fini, Niccolò Marchionni, Stefano Bonassi, Federica Mammarella, Walter Marrocco, Giuseppe Pozzi, Katie Palmer, Alessandro Monaco, Sergio Pecorelli, Luca Pani, on behalf of the Geriatrics Steering Committee of the Italian Medicines Agency on behalf of the OsMed Health-DB Network

Activity | Posttest | Credits: 1.00 | Expires: 12/31/2018 | Keywords: depression, medical conditions

Depression is common in the elderly, a population often having multiple prescribed treatments due to chronic multimorbidity. Read this CME article to learn how often antidepressants are prescribed and adhered to in this population and how antidepressant adherence affects overall medication adherence.

Simoons et al

JCP CME

Medication Discrepancies at Outpatient Departments for Mood and Anxiety Disorders in the Netherlands: Risks and Clinical Relevance

Mirjam Simoons, Hans Mulder, Arne J. Risselada, Frederik W. Wilmink, Robert Schoevers, Henricus G. Ruhé, and Eric N. van Roon

Activity | Posttest | Credits: 1.00 | Expires: 11/30/2018 | Keywords: depression, anxiety

Patients often take both psychiatric and general medical drugs, prescribed by different practitioners, as well as nonprescription drugs. If you lack complete and up-to-date medication data for your patients, how can you correctly evaluate their clinical status and adjust the medication regimen that you've prescribed? Read this CME article to learn about the need to improve medication reconciliation procedures.

Sakurai et al

JCP CME

Increasing Versus Maintaining the Dose of Olanzapine or Risperidone in Schizophrenia Patients Who Did Not Respond to a Modest Dosage: A Double-Blind Randomized Controlled Trial

Hitoshi Sakurai, Takefumi Suzuki, Robert R. Bies, Bruce G. Pollock, Masaru Mimura, Shitij Kapur, and Hiroyuki Uchida

Activity | Posttest | Credits: 1.00 | Expires: 10/31/2018 | Keyword: schizophrenia

When your patients with schizophrenia insufficiently respond to antipsychotic treatment, do you increase the dose? Do you check their plasma drug concentration? Read this CME article to find out whether increasing the dose provides any greater benefit than waiting longer for patients to respond to the lower dose.

Cox et al

JCP CME

The Perinatal Depression Treatment Cascade: Baby Steps Toward Improving Outcomes

Elizabeth Q. Cox, Nathaniel A. Sowa, Samantha E. Meltzer-Brody, and Bradley N. Gaynes

Activity | Posttest | Credits: 1.00 | Expires: 9/30/2018 | Keyword: depression

Perinatal depression is common and can have serious implications for both the mother and child. However, the authors of this review found that over 90% of women with antenatal or postpartum depression receive inadequate treatment. Read this CME activity so that your patients won't go undiagnosed and untreated.

Wilkinson et al

JCP CME

A Systematic Review of the Evidence for Medical Marijuana in Psychiatric Indications

Samuel T. Wilkinson, Rajiv Radhakrishnan, and Deepak Cyril D’Souza

Activity | Posttest | Credits: 1.00 | Expires: 8/31/2018 | Keywords: Alzheimer's, PTSD

Marijuana has been approved in many US states to treat a number of psychiatric conditions, including posttraumatic stress disorder, agitation in Alzheimer’s disease, and Tourette’s disorder. But what is the strength of evidence for the efficacy of marijuana and other cannabinoids for these psychiatric indications? Learn more by reading this CME journal article.

Wilens et al

JCP CME

Nonmedical Stimulant Use in College Students: Association With Attention-Deficit/Hyperactivity Disorder and Other Disorders

Timothy Wilens, Courtney Zulauf, MaryKate Martelon, Nicholas R. Morrison, Andrew Simon, Nicholas W. Carrellas, Amy Yule, and Rayce Anselmo

Activity | Posttest | Credits: 1.00 | Expires: 7/31/2018 | Keywords: substance use disorders, ADHD

Nonmedical use of prescription stimulants among college students is a growing public health problem. How can clinicians reduce stimulant misuse? Read this journal CME article to learn about the problem and what you can do about it.

Saha et al

JCP CME

Nonmedical Prescription Opioid Use and DSM-5 Nonmedical Prescription Opioid Use Disorder in the United States

Tulshi D. Saha, Bradley T. Kerridge, Risë B. Goldstein, S. Patricia Chou, Haitao Zhang, Jeesun Jung, Roger P. Pickering, W. June Ruan, Sharon M. Smith, Boji Huang, Deborah S. Hasin, and Bridget F. Grant

Activity | Posttest | Credits: 1.00 | Expires: 6/30/2018 | Keyword: substance use disorders

Although opioid analgesics are important components of treatment for chronic pain, prescriptions for opioid analgesics---as well as harms from their use---have skyrocketed during the last decade. Do you systematically screen patients for nonmedical prescription opioid use and educate them about the risks? Read this journal CME article for more information.

Fontanella et al

JCP CME

Benzodiazepine Use and Risk of Mortality Among Patients With Schizophrenia: A Retrospective Longitudinal Study

Cynthia A. Fontanella, John V. Campo, Gary S. Phillips, Danielle L. Hiance-Steelesmith, Helen Anne Sweeney, Kwok Tam, Douglas Lehrer, Robert Klein, and Mark Hurst

Activity | Posttest | Credits: 1.00 | Expires: 5/31/2018 | Keyword: schizophrenia

Do you prescribe benzodiazepines to your patients with schizophrenia? Learn more about the risk-benefit profile of this strategy by reading this journal CME study. The findings on mortality risk may surprise you.

Gotlib et al

JCP CME

Guideline Adherence for Mentally Ill Reproductive-Aged Women on Treatment With Valproic Acid: A Retrospective Chart Review

Dorothy Gotlib, Elizabeth Perelstein, Jacob Kurlander, Kara Zivin, Michelle Riba, and Maria Muzik

Activity | Posttest | Credits: 1.00 | Expires: 4/30/2018 | Keyword: bipolar disorder

Treating reproductive-aged female patients with valproic acid comes with serious teratogenic risks. Read this journal CME article to explore data on safety and clinical strategies.

Mota et al

JCP CME

Late-Life Exacerbation of PTSD Symptoms in US Veterans: Results From the National Health and Resilience in Veterans Study

Natalie Mota, Jack Tsai, Paul D. Kirwin, Ilan Harpaz-Rotem, John H. Krystal, Steven M. Southwick, and Robert H. Pietrzak

Activity | Posttest | Credits: 1.00 | Expires: 3/31/2018 | Keyword: PTSD

Do you see patients who are older military veterans? Did you know that some experience exacerbated posttraumatic stress disorder (PTSD) symptoms, possibly decades after their trauma? Read this journal CME activity to find out about the prevalence and determinants of PTSD exacerbations in older age.

Simon et al

JCP CME

Risk of Suicide Attempt and Suicide Death Following Completion of the Patient Health Questionnaire Depression Module in Community Practice

Gregory E. Simon, Karen J. Coleman, Rebecca C. Rossom, Arne Beck, Malia Oliver, Eric Johnson, Ursula Whiteside, Belinda Operskalski, Robert B. Penfold, Susan M. Shortreed, and Carolyn Rutter

Activity | Posttest | Credits: 1.00 | Expires: 2/28/2018 | Keyword: depression

When your patients complete the Patient Health Questionnaire, they are asked about the frequency of suicidal thoughts. For patients who indicate suicidal ideation, how long does their suicide risk last? How does clinical intervention change the risk? To learn more, read this journal CME study.

Lee et al

JCP CME

Antidepressant Treatment and Risk of Dementia: A Population-Based, Retrospective Case-Control Study

Cynthia Wei-Sheng Lee, Cheng-Li Lin, Fung-Chang Sung, Ji-An Liang, and Chia-Hung Kao

Activity | Posttest | Credits: 1.00 | Expires: 1/31/2018 | Keywords: depression, dementia

Previous studies have demonstrated that depression may be a risk factor for dementia. Does the risk of dementia change when people take antidepressants? Learn more about research findings in this journal CME study, which compared the histories of antidepressant use in patients with and without dementia.

Baer et al

JCP CME

Prevalence and Impact of Obsessive-Compulsive Symptoms in Depression: A STAR*D Report

Lee Baer, Madhukar H. Trivedi, Ilana Huz, A. John Rush, Stephen R. Wisniewski, and Maurizio Fava

Activity | Posttest | Credits: 1.00 | Expires: 12/31/2017 | Keywords: depression, obsessive-compulsive disorder

When you treat patients for major depressive disorder, do you screen them for obsessive-compulsive symptoms? Read this journal CME activity based on STAR*D data to learn more about how obsessions and compulsions affect depression remission and how you can identify them.

Olfson et al

JCP CME

Antipsychotic Treatment of Adults in the United States

Mark Olfson, Marissa King, and Michael Schoenbaum

Activity | Posttest | Credits: 1.00 | Expires: 10/31/2017 | Keywords: dementia, depression

When you prescribe antipsychotic agents, do you record a diagnosis of mental illness? Do you prescribe them long-term for patients with dementia? Read this journal CME activity to find out about prescription trends.

Wilkinson et al

JCP CME

Marijuana Use Is Associated With Worse Outcomes in Symptom Severity and Violent Behavior in Patients With Posttraumatic Stress Disorder

Samuel T. Wilkinson, Elina Stefanovics, Robert A. Rosenheck

Activity | Posttest | Credits: 1.00 | Expires: 9/30/2017 | Keyword: PTSD

Despite the lack of randomized controlled trials of marijuana in the treatment of PTSD, some US states have legalized this treatment strategy. Review this journal CME article to find out more about potential outcomes of this treatment.

Sullivan et al

JCP CME

Influence of Schizophrenia Diagnosis on Providers’ Practice Decisions

Greer Sullivan, Dinesh Mittal, Christina M. Reaves, Tiffany F. Haynes, Xiaotong Han, Snigdha Mukherjee, Scott Morris, Laura Marsh, and Patrick W. Corrigan

Activity | Posttest | Credits: 1.00 | Expires: 8/31/2017 | Keywords: schizophrenia, medical conditions

Do clinicians resemble the general public in terms of negatively viewing persons with mental illness? Read this journal CME activity to learn whether a diagnosis of schizophrenia in a case vignette influences providers’ clinical expectations and referral practices. Then, examine whether your own perspectives on the abilities and competence of high-functioning patients with schizophrenia are more negative than warranted.

Hoertel et al

JCP CME

Childhood Maltreatment and Risk of Suicide Attempt: A Nationally Representative Study

Nicolas Hoertel, Silvia Franco, Melanie M. Wall, Maria A. Oquendo, Shuai Wang, Frédéric Limosin, and Carlos Blanco

Activity | Posttest | Credits: 1.00 | Expires: 7/31/2017 | Keywords: personality disorders, depression, anxiety, substance use disorders

Which types of childhood maltreatment are associated with greater risk of suicide attempt in adulthood? Are child abuse or neglect associated with an earlier age at first suicide attempt? Do psychopathology and sociodemographic characteristics affect the association between childhood maltreatment and suicide attempt? Explore answers to these questions in this CME journal article.

Wisco et al

JCP CME

Posttraumatic Stress Disorder in the US Veteran Population: Results From the National Health and Resilience in Veterans Study

Blair E. Wisco, Brian P. Marx, Erika J. Wolf, Mark W. Miller, Steven M. Southwick, and Robert H. Pietrzak

Activity | Posttest | Credits: 1.00 | Expires: 12/31/2017 | Keyword: PTSD

When you assess veterans' trauma histories, do you include both combat- and noncombat-related traumas? Both types are common in veterans. The prevalence of PTSD in US veterans is slightly higher than that of the general US adult population, and veterans with PTSD have higher rates of other psychiatric disorders and suicidal behaviors than veterans without PTSD. Read this CME journal article to learn what types of interventions may benefit veterans with PTSD.

Smith et al

JCP CME

Depression and Multimorbidity: A Cross-Sectional Study of 1,751,841 Patients in Primary Care

Daniel J. Smith, Helen Court, Gary McLean, Daniel Martin, Julie Langan Martin, Bruce Guthrie, Jane Gunn, and Stewart W. Mercer

Activity | Posttest | Credits: 1.00 | Expires: 11/30/2017 | Keywords: depression, medical conditions

How do you help your patients receive coordinated medical and psychiatric care? A study of nearly 144,000 people with depression reports that 68% have at least 1 comorbid physical health condition. Read this journal CME article to see why health care systems must be structured to manage multiple conditions concurrently rather than to use a single-disease approach.

Godin et al

JCP CME

Metabolic Syndrome in a French Cohort of Patients With Bipolar Disorder: Results From the FACE-BD Cohort

Ophélia Godin, Bruno Etain, Chantal Henry, Thierry Bougerol, Philippe Courtet, Leroux Mayliss, Christine Passerieux, Jean-Michel Azorin, Jean-Pierre Kahn, Sebastien Gard, Dominique Costagliola, and Marion Leboyer for the FondaMental Advanced Centers of Expertise in Bipolar Disorders (FACE-BD) Collaborators

Activity | Posttest | Credits: 1.00 | Expires: 10/31/2017 | Keywords: bipolar disorder, medical conditions, None, None

Nearly 1 in 5 of your patients with bipolar disorder may have metabolic syndrome (MetS), and 16% to 36% may have components of it. Do you regularly assess patients for these abnormalities? Read this journal CME activity to learn about MetS risk factors and the need for integrated psychiatric and primary care for these patients.

Madsen et al

JCP CME

Postdeployment Suicidal Ideations and Trajectories of Posttraumatic Stress Disorder in Danish Soldiers: A 3-Year Follow-Up of the USPER Study

Trine Madsen, Karen-Inge Karstoft, Mette Bertelsen, and Søren Bo Andersen

Activity | Posttest | Credits: 1.00 | Expires: 9/30/2017 | Keywords: PTSD, None, None, None

Could the course of illness of posttraumatic stress disorder (PTSD) affect suicidal ideation among veterans? Read this CME activity from The Journal of Clinical Psychiatry to find out how rates of suicidal ideation differed among veterans with varying trajectories of PTSD over more than 2 and a half years.

Mittal et al

JCP CME

Demographic, Economic, and Clinical Correlates of Depression Treatment Response in an Underserved Primary Care Population

Dinesh Mittal, Lakshminarayana Chekuri, Liya Lu, and John C. Fortney

Activity | Posttest | Credits: 1.00 | Expires: 8/31/2017 | Keywords: depression, None, None, None

Can you predict your patients' depression treatment response using demographic, clinical, and socioeconomic variables? Read this CME activity from The Journal of Clinical Psychiatry to learn the results of a study of response to collaborative care for depression in federally qualified health centers.

Hackman et al

JCP CME

Prescription Drug Monitoring Program Inquiry in Psychiatric Assessment: Detection of High Rates of Opioid Prescribing to a Dual Diagnosis Population

Daniel T. Hackman, Marion S. Greene, Taya J. Fernandes, Ashley M. Brown, Eric R. Wright, and R. Andrew Chambers

Activity | Posttest | Credits: 1.00 | Expires: 7/31/2017 | Keywords: substance use disorders, None, None, None

How can you help to diminish the epidemic of prescription drug abuse, which is disproportionately affecting those with mental illness? In this CME article from The Journal of Clinical Psychiatry, learn why prescription drug monitoring program databases are powerful tools to recognize high frequencies of patient exposure to prescribed opioids and other drugs that are frequently abused.

Clinebell et al

JCP CME

Guidelines for Preventing Common Medical Complications of Catatonia: Case Report and Literature Review

Kimberly Clinebell, Pierre N. Azzam, Priya Gopalan, and Roger Haskett

Activity | Posttest | Credits: 1.00 | Expires: 6/30/2017 | Keywords: medical conditions, mental illness, bipolar disorder, schizophrenia

Catatonia places patients at risk for a wide range of medical complications ranging from mildly painful to potentially fatal. Read this CME case and literature review to learn about preventing and managing deep vein thrombosis and pulmonary embolism, pressure ulcers, muscular contractures, and nutritional deficiencies in inpatients with catatonia.

+PCC CME Activities [Series Home Page]

Thomas et al

PCC CME

Mental and Physical Health Conditions in US Combat Veterans: Results From the National Health and Resilience in Veterans Study

Melissa M. Thomas, Ilan Harpaz-Rotem, Jack Tsai, Steven M. Southwick, and Robert H. Pietrzak

Activity | Posttest | Credits: 1.00 | Expires: 6/30/2019 | Keywords: PTSD, generalized anxiety disorder, pain, medical conditions

Combat exposure has been linked to PTSD and other mental health conditions, but is it also linked to physical health conditions? Read this CME article to learn about how mental and physical conditions differ between veterans with and without combat exposure as well as between younger and older veterans with combat exposure.

Burke et al

PCC CME

Mood Versus Memory

Anna D. Burke, William J. Burke, Garrett H. Riggs, David A. Weidman, and Jacquelynn N. Copeland

Activity | Posttest | Credits: 1.00 | Expires: 4/30/2019 | Keywords: Alzheimer's, bipolar depression

The symptoms of dementia and depression frequently overlap. What are the best steps to take to differentiate between dementia and depression? Follow along with this case report to learn more about the diagnosis and treatment of a 50-year-old woman with cognitive impairment, bipolar II disorder, and a family history of Alzheimer's disease.

McCreath et al

PCC CME

Long-Acting Injectable Antipsychotics for Schizophrenia: Sociodemographic Characteristics and Treatment Adherence

James McCreath, Essie Larson, Purabi Bharatiya, Hisham A. Labanieh, Zvi Weiss, and Michael Lozovatsky

Activity | Posttest | Credits: 1.00 | Expires: 2/28/2019 | Keyword: schizophrenia

It is crucial that we find ways to support medication adherence for patients with schizophrenia. Long-acting injectable antipsychotic (LAI) medications are an option. In this CME study, the authors retrospectively assessed variables that factor into an individual’s adherence to LAIs.

Tatreau et al

PCC CME

Cardiometabolic Assessment, Diagnosis, and Treatment of Chronic Medical Illnesses During an Inpatient Psychiatric Hospitalization: Colocated Medical Care Versus Treatment as Usual

Jason R. Tatreau, Suzanne Harris, Brian Sheitman, and Beat D. Steiner

Activity | Posttest | Credits: 1.00 | Expires: 12/31/2018 | Keyword: schizophrenia

Much attention has been paid in recent years to increasing the recognition and treatment of mental illnesses in the primary care setting, but what about the reverse? In psychiatric inpatient settings, can the screening, diagnosis, and treatment of chronic medical comorbidities be improved? Read this CME article to learn more.

Penders et al

PCC CME

Bright Light Therapy as Augmentation of Pharmacotherapy for Treatment of Depression: A Systematic Review and Meta-Analysis

Thomas M. Penders, Cornel N. Stanciu, Alexander M. Schoemann, Phillip T. Ninan, Richard Bloch, and Sy A. Saeed

Activity | Posttest | Credits: 1.00 | Expires: 10/11/2019 | Keyword: depression

When your patients' depressive episodes have not fully remitted with antidepressant therapy, do you consider augmenting with bright light therapy? This treatment modality is accepted for seasonal depression, but a meta-analysis suggests that its efficacy extends to nonseasonal episodes as well. Learn more in this journal CME activity.

Weidman et al

PCC CME

At a Loss for Words

David A. Weidman, Anna D. Burke, Garret H. Riggs, Helle Brand, Jacquelynn N. Copeland, and William J. Burke

Activity | Posttest | Credits: 1.00 | Expires: 8/31/2018 | Keywords: Alzheimer's, dementia

Read this CME case to meet a 70-year-old patient who has experienced speech changes that have gradually progressed for 4 years. She has had problems with word-finding, mispronunciations, mild stuttering, and made-up words, and, in the past year, she's begun having functional impairments. Follow along with colleagues through diagnosis and treatment steps.

Flynn et al

PCC CME

Student Evaluation of the Yellow Ribbon Suicide Prevention Program in Midwest Schools

Alexandra Flynn, Rosalee Zackula, Nicole M. Klaus, Liz McGinness, Susan Carr, and Matthew Macaluso

Activity | Posttest | Credits: 1.00 | Expires: 6/30/2018 | Keyword: mental illness

Did you know that suicide is the second leading cause of death in adolescents? The US Surgeon General recommends implementing school programs to address adolescent distress, provide crisis intervention, and incorporate peer support for seeking help. Read this CME journal article about the results of a school-based suicide prevention program. Then, investigate school programs in your area, and screen young patients for suicidality.

Weinreb et al

PCC CME

Managing Depression Among Homeless Mothers: Pilot Testing an Adapted Collaborative Care Intervention

Linda Weinreb, Carole C. Upshur, Debbian Fletcher-Blake, George Reed, and Christine Frisard

Activity | Posttest | Credits: 1.00 | Expires: 4/30/2018 | Keyword: depression

Homeless mothers have high rates of mental and physical health problems and often have had multiple traumatic experiences. Although depression is common, most homeless mothers do not receive treatment for it. Therefore, targeting this population for depression screening in primary care settings, including shelter-based clinics, has the potential to more readily engage these women in treatment for depression and their other medical and mental health issues. Read this CME article to learn more.

Burke et al

PCC CME

Movements and Memory

Anna D. Burke, Garret H. Riggs, David A. Weidman, Helle Brand, and William J. Burke

Activity | Posttest | Credits: 1.00 | Expires: 2/28/2018 | Keyword: dementia

Follow along as Mr A, an 82-year-old man with cognitive impairment, is evaluated and treated. His symptoms include getting lost while driving, forgetting conversations and events, and having disturbed sleep. Mr A also has mild tremors in his hands and some dizziness. What are the best diagnosis and treatments for Mr A?

Chakravorty et al

PCC CME

Sleep Duration and Insomnia Symptoms as Risk Factors for Suicidal Ideation in a Nationally Representative Sample

Subhajit Chakravorty, H.Y. Katy Siu, Linden Lalley-Chareczko, Gregory K. Brown, James C. Findley, Michael L. Perlis, and Michael A. Grandner

Activity | Posttest | Credits: 1.00 | Expires: 12/31/2017 | Keywords: sleep disorders, depression

Do you screen for depressive disorder and suicidal ideation in patients complaining of insomnia and abnormal sleep duration? Read this journal CME article to learn about recent research on this topic.

Czech et al

PCC CME

Association Between Specific Depression Symptoms and Glycemic Control Among Patients With Comorbid Type 2 Diabetes and Provisional Depression

Stephanie J. Czech, Susan M. Orsillo, Paul A. Pirraglia, Thomas M. English, and Alexa J. Connell

Activity | Posttest | Credits: 1.00 | Expires: 10/31/2017 | Keywords: depression, medical conditions, insomnia

Do you treat patients with type 2 diabetes who also have depression? Did you know that assessing and managing sleep problems might improve glycemic control in these patients? Read this journal CME article for more information.

Madan et al

PCC CME

Reducing Adverse Polypharmacy in Patients With Borderline Personality Disorder: An Empirical Case Study

Alok Madan, John M. Oldham, Sylvia Gonzalez, and J. Christopher Fowler

Activity | Posttest | Credits: 1.00 | Expires: 8/31/2017 | Keywords: personality disorders, medical conditions

How can outcomes be improved in patients with borderline personality disorder? Have you considered that reducing polypharmacy could help? Read this CME journal case study to follow a patient's symptoms and well-being as her medication regimen is simplified from admission to discharge and afterwards.

Flynn et al

PCC CME

Wernicke’s Encephalopathy: Increasing Clinician Awareness of This Serious, Enigmatic, Yet Treatable Disease

Alexandra Flynn, Matthew Macaluso, Inna D’Empaire, and Megan M. Troutman

Activity | Posttest | Credits: 1.00 | Expires: 6/30/2017 | Keywords: medical conditions, mental illness, substance use disorders

Permanent brain damage, long-term institutionalization, and death can result from undiagnosed and untreated Wernicke’s encephalopathy. Too many cases are not diagnosed until autopsy. Do you know which patients are at risk? Read this journal CME article to review the clinical diagnosis and effective treatment for this medical emergency.

Shahla Mohsenin and Vahid Mohsenin

PCC CME

Diagnosis and Management of Sleep Disorders in Posttraumatic Stress Disorder: A Review of the Literature

Shahla Mohsenin, MD, and Vahid Mohsenin, MD

Activity | Posttest | Credits: 1.00 | Expires: 12/31/2017 | Keywords: PTSD, sleep disorders

How well are sleep problems being managed in your patients with PTSD? Insomnia, nightmares, sleep apnea, and sleep movement disorders are common in these patients. Read this journal CME activity to learn about diagnosing and managing these conditions so that you can better help your patients with PTSD.

Shane J. McInerney and Sidney H. Kennedy

PCC CME

Review of Evidence for Use of Antidepressants in Bipolar Depression

Shane J. McInerney, MB, MSc, MRCPsych, and Sidney H. Kennedy, MD, FRCPC

Activity | Posttest | Credits: 1.00 | Expires: 10/31/2017 | Keywords: bipolar depression, None, None, None

Antidepressants are used in up to 50% of patients with bipolar depression. Do you prescribe them for your patients? Read this brief review to find out whether antidepressants work in bipolar depression and whether any benefits exceed risks, such as induction of (hypo)mania and rapid cycling.

Blasco-Fontecilla et al

PCC CME

A Cross-Sectional Study of Major Repeaters: A Distinct Phenotype of Suicidal Behavior

Hilario Blasco-Fontecilla, MD, PhD; Isabelle Jaussent, PhD; Emilie Olié, MD, PhD; Severine Béziat, MSc; Sebastien Guillaume, MD, Paula Artieda-Urrutia, Enrique Baca-Garcia, Jose de Leon, and Philippe Courtet

Activity | Posttest | Credits: 1.00 | Expires: 8/31/2017 | Keywords: substance use disorders, eating disorders, depression, None

Can people become addicted to suicidal behavior? Do individuals who attempt suicide 5 times or more represent a distinct phenotype among those with suicidal behavior? Read this journal CME article to learn more about the demographic and clinical characteristics of patients who repeatedly attempt suicide.

Ionescu et al

PCC CME

Pharmacologic Treatment of Dimensional Anxious Depression: A Review

Dawn F. Ionescu, Mark J. Niciu, Erica M. Richards, and Carlos A. Zarate, Jr

Activity | Posttest | Credits: 1.00 | Expires: 6/30/2017 | Keywords: depression, anxiety, None, None

Did you know that anxious symptoms affect about half of patients with depression? To note the effects of anxiety within depression, the DSM-5 added an “anxious distress” specifier to the diagnosis of major depressive disorder. In this CME activity from The Primary Care Companion, read about the outcomes and side effect burden associated with anxious depression.

+Advanced Topics in Major Depressive Disorder: Practical Strategies to Improve Remission [Series Home Page]

Rakesh Jain

Health Spectrum

Advanced Topics in Major Depressive Disorder: Practical Strategies to Improve Remission

Rakesh Jain, MD, MPH

Activity | Posttest | Credits: 2.00 | Expires: 4/30/2018 | Keyword: depression

Most patients with major depressive disorder will not achieve remission with initial treatment. Strategies to increase the likelihood of achieving remission include regularly measuring response, assessing adverse effects and adherence, addressing non-mood symptoms, and knowing when to switch or augment antidepressants. In this CME Health Spectrum activity, follow 2 patient cases that illustrate these topics.

+Challenges in the Recognition and Treatment of Binge-Eating Disorder [Series Home Page]

Susan G. Kornstein (Chair) et al

Journal Supplement

Challenges in the Recognition and Treatment of Binge-Eating Disorder

Susan G. Kornstein, MD (Chair), et al

Activity | Posttest | Credits: 3.00 | Expires: 1/31/2019 | Keyword: eating disorders

Binge-eating disorder (BED) is the most common eating disorder but is often overlooked. Consequences of binge eating may include psychological distress, obesity, and metabolic symptoms. Read this CME Supplement to better recognize the signs and symptoms of BED and to provide appropriate evidence-based care.

+Biological Therapies in Psychiatry Newsletter 2016 [Series Home Page]

+Recognition and Treatment of Pediatric Bipolar Disorder [Series Home Page]

Robert L. Findling (Chair) et al

Journal Supplement

Recognition and Treatment of Pediatric Bipolar Disorder

Robert L. Findling, MD, MBA (Chair), et al

Activity | Posttest | Credits: 3.00 | Expires: 8/31/2018 | Keywords: bipolar disorder, bipolar mania, bipolar depression

Do you find the diagnosis and treatment of pediatric bipolar disorder challenging? Read this CME supplement to learn about the phenomenology and differential diagnosis of bipolar disorders in children and adolescents as well as evidence-based pharmacologic and psychotherapeutic interventions. With effective treatment and the support of their families, young patients with bipolar disorder can learn to manage the illness and become independent, healthy adults.

+Improving the Care and Management of Patients With Inadequate Response to Depression Treatment [Series Home Page]

Michael E. Thase

Case & Comment

Managing Medical Comorbidities in Patients With Depression to Improve Overall Prognosis

Michael E. Thase, MD

Activity | Posttest | Credits: 0.50 | Expires: 7/31/2018 | Keywords: depression, medical conditions

What additional precautions should be taken when a patient presents with symptoms of depression as well as medical comorbidities? Consider the options as you review this new Case and Comment activity about Tony, a 64-year-old man whose treatment-resistant depression is more difficult to manage due to medical conditions.

George I. Papakostas

Case & Comment

Identifying Patients Who Need a Change in Depression Treatment and Implementing That Change

George I. Papakostas, MD

Activity | Posttest | Credits: 0.50 | Expires: 6/30/2018 | Keyword: depression

What steps should be taken when you are presented with a patient who has been previously treated by a primary care provider but has been unresponsive to treatment? Gain insight into the challenges of treatment-resistant depression by exploring this new Case and Comment activity focused on Robert, a 55-year-old accountant.

Roger S. McIntyre

Case & Comment

Implementing Appropriate Treatment Strategies for Varying Types of Depression

Roger S. McIntyre, MD, FRCPC

Activity | Posttest | Credits: 0.50 | Expires: 4/30/2018 | Keywords: depression, bipolar disorder, anxiety

What steps should be taken when your patient does not respond adequately to antidepressant medication and has symptoms that may indicate the presence of several diagnoses? Review this Case and Comment activity to analyze the case of Melissa, an architect whose treatment-resistant depression may be masking other diagnoses.

Bradley Gaynes

Case & Comment

Recognizing and Assessing Risk Factors for Difficult-to-Treat Depression and Treatment-Resistant Depression

Bradley Gaynes, MD, MPH

Activity | Posttest | Credits: 0.50 | Expires: 4/30/2018 | Keyword: depression

What should you do when your patients do not respond adequately to antidepressant therapy? Review this new Case and Comment activity to learn more about Alice's depressive episode and how you can help your patients like Alice achieve remission.

Bradley Gaynes (Chair), et al

Journal Supplement

Improving the Care and Management of Patients With Inadequate Response to Depression Treatment

Bradley Gaynes, MD, MPH (Chair), et al

Activity | Posttest | Credits: 2.50 | Expires: 1/31/2018 | Keyword: depression

With only about one-third of patients with depression responding to their initial treatment trial, clinicians face the challenge of managing patients with poor response or treatment-resistant depression. In this Supplement, learn to identify difficult-to-treat types of depression, to select evidence-based treatments, to adjust treatment in a timely manner, and to coordinate care of comorbid conditions to improve patient outcomes.

+Enhancing Approaches to the Identification and Management of Pseudobulbar Affect [Series Home Page]

David W. Crumpacker

Psychlopedia

Enhancing Approaches to the Identification and Management of Pseudobulbar Affect

David W. Crumpacker, MD

Activity | Posttest | Credits: 1.00 | Expires: 7/31/2017 | Keywords: medical conditions, depression

Pseudobulbar affect has been unrecognized and untreated for too long. Engage in this activity and watch its brief videos to learn about this embarrassing, socially limiting condition so you can better help your patients.

+Test Series [Series Home Page]

+Achieving Remission and Recovery in Depression With Anxiety [Series Home Page]

Andrew Cutler

Psychlopedia

The Role of Insomnia in Depression and Anxiety: Its Impact on Functioning, Treatment, and Outcomes

Andrew J. Cutler, MD

Activity | Posttest | Credits: 0.50 | Expires: 4/30/2018 | Keywords: depression, insomnia, anxiety

The case of 42-year-old Mrs C illustrates the common combination of anxious depression and sleep problems. In this activity, learn about the relationship between these disorders and find effective strategies to treat insomnia with depression and anxiety.

David Sheehan

Psychlopedia

Importance of Restoring Function in Patients With Major Depressive Disorder

David V. Sheehan, MD, MBA

Activity | Posttest | Credits: 0.50 | Expires: 3/31/2018 | Keyword: depression

Restoring function in areas like home, work, and relationships is an important treatment goal for patients with depression. Here, find practical rating scales to monitor areas of functioning and discover specific interventions to target these impairments.

Larry Culpepper

Psychlopedia

Impact of Anxious Symptoms and Comorbid Anxiety Disorders on Functional Impairment in Depressed Patients

Larry Culpepper, MD, MPH

Activity | Posttest | Credits: 0.50 | Expires: 2/28/2018 | Keywords: depression, anxiety

Explore this activity to understand the relationship between, and impact of, depression and anxiety, and discover strategies to assess and treat both depressive and anxious symptoms in your patients.

+Measuring and Managing Cognitive Impairment in Schizophrenia [Series Home Page]

S. Charles Schulz (Chair), et al

Journal Supplement

Measuring and Managing Cognitive Impairment in Schizophrenia

S. Charles Schulz, MD (Chair), et al

Activity | Posttest | Credits: 2.00 | Expires: 2/28/2018 | Keyword: schizophrenia

Cognitive impairment is present in almost all patients with schizophrenia, yet it often receives less clinical attention than positive and negative symptoms. Read this supplement to help identify, monitor, and manage these symptoms in your patients.

+Sleep Disorders in the Psychiatric Setting [Series Home Page]

Krystal and Sorscher

Webcast

Recognizing and Managing Insomnia in Primary Care and Specialty Settings

Andrew D. Krystal, MD, MS (chair), and Adam J. Sorscher, MD

Activity | Posttest | Credits: 1.00 | Expires: 2/28/2018 | Keyword: insomnia

Watch this webcast to see two patient cases with different sleep difficulties. Listen as the faculty discuss these cases and give evaluation tools and treatment strategies that will help you manage patients with sleep problems in your own practice.

+Biological Therapies in Psychiatry 2015 [Series Home Page]

+Strategies to Improve Outcomes for Primary Care Patients With Major Depressive Disorder [Series Home Page]

Rakesh Jain et al

PCC CME

Improving Outcomes for Primary Care Patients With Depression

Rakesh Jain, MD, MPH (Chair), et al

Activity | Posttest | Credits: 1.00 | Expires: 12/31/2017 | Keyword: depression

How do you assess symptom resolution, treatment adherence, and tolerability in your patients with depression? Follow the 3 patient cases in this CME newsletter to learn how measurement-based care can help you monitor treatment, improve adherence and patient outcomes, and recognize and treat residual symptoms.

C. Brendan Montano

Psychlopedia

Tactics to Improve Adherence in Depressed Primary Care Patients

C. Brendan Montano, MD

Activity | Posttest | Credits: 0.50 | Expires: 9/30/2017 | Keyword: depression

Do your patients with depression have trouble with medication adherence? Follow as Mr K, a 28-year-old patient, stops adhering to his antidepressant due to adverse effects, and learn techniques for questioning your patients, collecting their information, and providing them with clear instructions to improve adherence.

W. Clay Jackson

Psychlopedia

The Benefits of Measurement-Based Care for Primary Care Patients With Depression

W. Clay Jackson, MD, DipTh

Activity | Posttest | Credits: 0.50 | Expires: 8/31/2017 | Keyword: depression

What treatment strategies do you consider for your patients who fail to respond to initial antidepressant treatment? Read the case of Mrs C to see how measurement-based care helps confirm her diagnosis, track symptom response, and assess her sense of well-being and to learn strategies for treating suboptimal response.

Rakesh Jain, MD, MPH

Psychlopedia

The Identification and Resolution of Residual Symptoms in Depressed Primary Care Patients

Rakesh Jain, MD, MPH

Activity | Posttest | Credits: 0.50 | Expires: 6/30/2017 | Keyword: depression

Like many patients being treated for depression, 86-year-old Mrs J does not recognize the residual symptoms she is experiencing. Follow her case as her psychiatrist uses several tools including rating scales and collateral information to identify her continuing symptoms and then considers different treatment strategies based on her age and symptoms.

+Recognizing and Treating Excessive Daytime Sleepiness and Narcolepsy [Series Home Page]

Thomas Roth (Chair) et al

JCP CME

Managing Excessive Daytime Sleepiness

Thomas Roth, PhD (Chair), and Russell P. Rosenberg, PhD

Activity | Posttest | Credits: 1.00 | Expires: 11/30/2017 | Keywords: narcolepsy, sleep disorders

Your patients' safety may be at risk if they have unrecognized excessive daytime sleepiness (EDS). Read this Commentary to learn how to assess EDS, to recognize any underlying conditions, and to select appropriate behavioral and pharmacologic strategies to treat both EDS and associated conditions.

Russell Rosenberg

Psychlopedia

Clinical Assessment of Excessive Daytime Sleepiness in the Diagnosis of Sleep Disorders

Russell P. Rosenberg, PhD

Activity | Posttest | Credits: 0.50 | Expires: 8/31/2017 | Keywords: narcolepsy, sleep disorders

Physicians who are not sleep specialists often feel they lack knowledge about sleep disorders. Read this Psychlopedia activity to familiarize yourself with disorders associated with excessive daytime sleepiness and the assessment methods used to diagnose these disorders.

Russell Rosenberg

Psychlopedia

Recommended Treatment Strategies for Patients With Excessive Daytime Sleepiness

Russell P. Rosenberg, PhD

Activity | Posttest | Credits: 0.50 | Expires: 8/31/2017 | Keywords: narcolepsy, sleep disorders

Given the prevalence of sleep disorders, too few sleep specialists are available. Therefore, other health care providers, especially primary care clinicians, need to know about the diagnosis of sleep disorders and the therapeutic options available to treat them. Read this Psychlopedia activity to increase your ability to select appropriate treatment strategies for sleep disorders.

Thomas Roth, PhD

Psychlopedia

The Effect of Comorbid Psychiatric and Medical Illnesses on Sleep Disorder Treatment

Thomas Roth, PhD

Activity | Posttest | Credits: 0.50 | Expires: 7/31/2017 | Keywords: narcolepsy, sleep disorders

Unrecognized conditions may be contributing to symptoms of daytime sleepiness and/or fatigue in your patients with sleep disorders. Learn about psychiatric, neurologic, and medical conditions that frequently coexist with sleep disorders and discover treatment strategies, both pharmacologic and nonpharmacologic, to improve patient outcomes.

Thomas Roth, PhD

Psychlopedia

Effects of Excessive Daytime Sleepiness and Fatigue on Overall Health and Cognitive Function

Thomas Roth, PhD

Activity | Posttest | Credits: 0.50 | Expires: 7/31/2017 | Keywords: narcolepsy, sleep disorders

Excessive daytime sleepiness (EDS) and fatigue can lead to accidents or unemployment if left unrecognized and untreated in your patients. In this Psychlopedia activity, discover patient-report scales and objective measures to screen for these symptoms and learn to recognize common disorders that may cause or contribute to EDS/fatigue.

+Complicated Major Depressive Disorder [Series Home Page]

+What Psychiatric Nurses Need to Know About Bipolar Disorder [Series Home Page]

Joanne Iennaco and Julie Carbray

Game Case

Engaging Patients in Long-Term Management of Bipolar Disorder

Joanne DeSanto Iennaco, PhD, PMHNP-BC, APRN, and Julie A. Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Activity | Posttest | Credits: 0.50 | Expires: 11/30/2017 | Keyword: bipolar disorder

What strategies do you use to get patients with bipolar disorder to participate in their illness management? Play this game-based activity to see if you can help a long-term patient with bipolar disorder learn the importance of adhering to treatment, tracking mood states, and making important lifestyle changes.

Joanne Iennaco and Julie Carbray

Game Case

Communicating With Colleagues and Patients About Acute Bipolar Disorder

Joanne DeSanto Iennaco, PhD, PMHNP-BC, APRN, and Julie A. Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Activity | Posttest | Credits: 0.50 | Expires: 10/31/2017 | Keywords: bipolar disorder, bipolar mixed episodes

Play your way to CME credit! This game-based activity lets you test your knowledge of assessment tools, treatment response, and patient education as you help 24-year-old Kate recover from her latest bipolar episode.

Julie Carbray and Joanne Iennaco

Game Case

Recognizing Signs and Symptoms of Bipolar Disorder

Julie A. Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, and Joanne DeSanto Iennaco, PhD, PMHNP-BC, APRN

Activity | Posttest | Credits: 0.50 | Expires: 8/31/2017 | Keywords: bipolar disorder, bipolar mixed episodes

This activity lets you earn CME credit and learn the signs and symptoms of bipolar disorder—while playing games! You’ll follow the case of David, a 20-year-old college student while uncovering rating scales and diagnostic criteria that can help with patient assessment.

+Using Mechanism of Action to Choose Medications for Treatment-Resistant Depression [Series Home Page]

Thomas Schwartz

Case & Comment

Why Is Mechanism of Action Important in Antidepressant Treatment?

Thomas L. Schwartz, MD

Activity | Posttest | Credits: 0.50 | Expires: 9/30/2017 | Keyword: depression

How do you handle patients who do not respond adequately to SSRI treatment? Explore this new Case and Comment to compare Maria's response to different antidepressant medications and learn more about how to effectively choose a therapeutic strategy for your patients.

Michael E. Thase

Case & Comment

How Does Understanding Mechanism of Action Help Clinicians Personalize Antidepressant Treatment Choices?

Michael E. Thase, MD

Activity | Posttest | Credits: 0.50 | Expires: 9/30/2017 | Keywords: depression, bipolar depression

Patients may experience a symptom profile that changes over time, such as a patient who first appears to have unipolar depression but later exhibits signs of mania or hypomania. Here, follow the case of Adam, a 30-year-old man, who is experiencing a recurrence of depression, and track his response through several antidepressant trials.

Michael E. Thase

Case & Comment

What Are the Mechanisms of Action of Current Antidepressant Treatments?

Michael E. Thase, MD

Activity | Posttest | Credits: 0.50 | Expires: 9/30/2017 | Keyword: depression

Therapeutic effects of antidepressants may vary greatly from patient to patient, with some patients failing to respond after several treatment trials. In this Case and Comment activity, follow the treatment steps taken for a 62-year-old surgeon with a treatment-resistant depressive episode.

Michael E. Thase, MD (Chair), et al

JCP CME

Choosing Medications for Treatment-Resistant Depression Based on Mechanism of Action

Michael E. Thase, MD (Chair), and Thomas L. Schwartz, MD

Activity | Posttest | Credits: 1.00 | Expires: 6/30/2017 | Keyword: depression

What can you do for your patients with depression who show partial response or no response to treatment? Follow a discussion by expert faculty about how altering levels of dopamine, norepinephrine, and serotonin in the brain may theoretically target specific depressive symptoms and how the mechanisms of action of different antidepressant classes are associated with therapeutic benefits and adverse effects.

+Barriers to Remission in Major Depressive Disorder: Residual Symptoms, Functional Impairment, and Medication Mechanism of Action [Series Home Page]

Pierre Blier

Psychlopedia

Neurobiology of Depression and Mechanism of Action of Depression Treatments

Pierre Blier, MD, PhD

Activity | Posttest | Credits: 0.50 | Expires: 10/31/2017 | Keyword: depression

Antidepressants, including SSRIs, may alleviate depressive symptoms but leave residual symptoms. In this activity, discover the mechanism of action of antidepressants and adjunctive agents and how to choose effective strategies to target specific symptoms or block/activate specific receptors for broader therapeutic benefits.

Larry Culpepper

Psychlopedia

Functional Impairment and Improvement in Depression

Larry Culpepper, MD, MPH

Activity | Posttest | Credits: 0.50 | Expires: 8/31/2017 | Keyword: depression

Unresolved symptoms of depression can cause functional impairment and negatively affect patients' work performance, home life, and relationships. In this Psychlopedia activity, learn how to assess functional impairments using validated rating scales and to address contributors to functional impairment.

Andrew A. Nierenberg, MD

Psychlopedia

Residual Symptoms in Depression: Prevalence and Impact

Andrew A. Nierenberg, MD

Activity | Posttest | Credits: 0.50 | Expires: 7/31/2017 | Keyword: depression

While mood symptoms may remit in your patients with depression, lack of motivation and negative affect may keep patients from achieving full recovery. Here, learn how these residual symptoms hinder your patients' function and discover tools to assess quality of life and positive affect.

+Criminal Forensic Psychiatry [Series Home Page]

Scott Freeman

Psychlopedia

Criminal Forensic Psychiatry: A Primer for Psychiatrists

Scott A. Freeman, MD

Activity | Posttest | Credits: 0.50 | Expires: 9/30/2017 | Keyword: mental illness

How is mental illness assessed and treated within the judicial system? Many mentally ill people spend time in correctional settings, and psychiatrists are involved in their evaluation and treatment. Participate in this Psychlopedia activity to find out about competency to stand trial and the insanity defense.

+Cognition in the Depressed Patient [Series Home Page]

+Understanding and Coping With Binge Eating Disorder: The Patient’s Perspective [Series Home Page]

Susan L. McElroy, MD (chair), and Anna I. Guerdjikova, PhD, LISW, CCRC

Webcast

Understanding and Coping With Binge Eating Disorder: The Patient’s Perspective

Susan L. McElroy, MD (chair), and Anna I. Guerdjikova, PhD, LISW, CCRC

Activity | Posttest | Credits: 1.00 | Expires: 6/30/2017 | Keywords: eating disorders, depression

Patients with BED will likely seek treatment for another problem like depression or weight loss rather than admit their eating behaviors. Watch this webcast to learn how to assess for and diagnose BED in patients with comorbid conditions and to understand the current pharmacologic and nonpharmacologic treatment options available for patients with this condition.

+Overcoming Challenges in the Diagnosis and Management of ADHD in African American Adults [Series Home Page]

Anthony L. Rostain

Psychlopedia

Health Care–Seeking Behaviors of African American ADHD Patients and Their Families: Overcoming Economic and Cultural Barriers

Anthony L. Rostain, MD

Activity | Posttest | Credits: 0.50 | Expires: 11/30/2017 | Keywords: ADHD, None, None, None

Do you know what keeps many African American patients from seeking treatment for mental health conditions? Read this new Psychlopedia activity to learn about barriers your African American patients face when seeking mental health services and to implement strategies to improve their care.

Roberta Waite

Psychlopedia

Culturally Competent Approaches to Assessing ADHD in African American Adults and Overcoming Cultural Issues With Patients and Families

Roberta Waite, EdD, PMHCNS-BC, FAAN

Activity | Posttest | Credits: 0.50 | Expires: 10/31/2017 | Keywords: ADHD, None, None, None

The history of racism within the field of psychiatry still affects African American patients today, making it difficult to diagnose psychiatric illness. Read this Psychlopedia to assess patients’ resistance toward psychiatric treatment in a culturally informed way and to better diagnose and treat African American patients with ADHD.

J. Russell Ramsay

Psychlopedia

Health Care Systems Issues and Disparities in ADHD Care for African American Adults

J. Russell Ramsay, PhD

Activity | Posttest | Credits: 0.50 | Expires: 10/31/2017 | Keywords: ADHD, None, None, None

African American adults with ADHD are underdiagnosed and undertreated. Explore this activity to learn about issues involving the health care system and disparities in care for African American adults, and discover how you can further assess patient and provider cultural biases toward ADHD symptoms and treatment.

+Cause and Effect in Bipolar Depression: Misdiagnosis Leads to Inappropriate Treatment, Clinical Complications, and Adverse Outcomes [Series Home Page]

+New Strategies in Sleep [Series Home Page]

+Challenges in the Recognition and Management of ADHD in Hispanic Adults in the United States [Series Home Page]

Anthony L. Rostain

Psychlopedia

Cultural Issues, Myths, Misinformation, and Health Care–Seeking Behaviors of Hispanic Patients With ADHD and Their Families

Anthony L. Rostain, MD

Activity | Posttest | Credits: 0.50 | Expires: 10/31/2017 | Keywords: ADHD, None, None, None

About two-thirds of Hispanic people in the United States may not receive treatment for mental illnesses such as ADHD. Read this new Psychlopedia activity to learn about barriers to your Hispanic patients receiving mental health services and to acquire practical steps to address these barriers.

Juan Pedraza

Psychlopedia

Culturally Competent Approaches to Diagnosing ADHD in Hispanic Adults and Overcoming Cultural Issues With Patients and Families

Juan Pedraza, MD

Activity | Posttest | Credits: 0.50 | Expires: 10/31/2017 | Keywords: ADHD, None, None, None

Hispanics are the most prevalent and diverse minority group in the US, and treating Hispanic adults for ADHD can be difficult. Read this Psychlopedia to learn about the unique characteristics and needs of Hispanic individuals with ADHD and use this knowledge to provide culturally competent diagnosis and treatment.

Yamalis Diaz

Psychlopedia

Health Care Systems Issues and Disparities in ADHD Care for Hispanic Adults

Yamalis Diaz, PhD

Activity | Posttest | Credits: 0.50 | Expires: 8/31/2017 | Keywords: ADHD, None, None, None

Hispanic adults with ADHD encounter numerous barriers when seeking treatment. Read this Psychlopedia to learn how to assess a Hispanic patient’s cultural biases toward ADHD diagnosis and treatment options.

+Making Connections Between Science and Symptoms in Schizophrenia [Series Home Page]

John M. Kane

Psychlopedia

The Role of NMDA Receptors in Schizophrenia

John M. Kane, MD

Activity | Posttest | Credits: 0.50 | Expires: 7/31/2017 | Keywords: schizophrenia, None, None, None

NMDA receptor function mediates the downstream release of neurotransmitters thought to be involved in schizophrenia, including dopamine, glutamate, and GABA. Here, review the function of NMDA receptors and find out about their possible role as a novel treatment target for schizophrenia.

Anissa Abi-Dargham

Psychlopedia

Schizophrenia: Overview and Dopamine Dysfunction

Anissa Abi-Dargham, MD

Activity | Posttest | Credits: 0.50 | Expires: 7/31/2017 | Keywords: schizophrenia, None, None, None

Excess dopamine and abnormal dopamine synthesis cause the positive symptoms of schizophrenia, but does this dysfunction also account for the negative and cognitive symptoms seen in this disorder? Here, get an overview of dopamine dysfunction and find out why this treatment target may be limited for patients with schizophrenia.

+Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder [Series Home Page]

Mary K. Colvin and Theodore A. Stern

Virtual Rounds in Neurology

Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder

Mary K. Colvin, PhD, and Theodore A. Stern, MD

Activity | Posttest | Credits: 1.00 | Expires: 12/31/2017 | Keyword: ADHD

Have you wondered how you could reliably make a diagnosis of ADHD and differentiate it from a learning disorder or another psychiatric condition? If you have, then this case vignette and discussion should prove useful in your evaluation and management of patients and their families.

+Biological Therapies in Psychiatry 2014 [Series Home Page]

+Treating and Caring for the Patient With Moderate-to-Severe Alzheimer's Disease [Series Home Page]

William J. Burke

Neurology Reports

Managing Patients With Moderate-to-Severe Alzheimer’s Disease: Expectations, Treatments, and Prognosis

William J. Burke, MD

Activity | Posttest | Credits: 0.50 | Expires: 12/31/2017 | Keywords: Alzheimer's, None, None, None

In this Neurology Report, experts from Banner Alzheimer’s Institute summarize ways to effectively communicate with patients and caregivers about an Alzheimer’s disease diagnosis and prognosis. Plus, they cover how to select appropriate treatments to slow functional decline and manage troublesome behavioral and psychological symptoms.

Jan Dougherty

Neurology Reports

Effective Communication Strategies to Help Patients and Caregivers Cope With Moderate-to-Severe Alzheimer’s Disease

Jan Dougherty, RN, MS

Activity | Posttest | Credits: 0.50 | Expires: 12/31/2017 | Keywords: Alzheimer's, None, None, None

Language impairment may cause more difficulty than memory impairment among caregivers and patients with Alzheimer's disease. Gain knowledge of ways to educate caregivers about communication problems, mistakes to avoid, and effective strategies to improve communication.

+The Impact of Oral Medications on the Treatment of Multiple Sclerosis [Series Home Page]

Clyde E. Markowitz

Neurology Reports

Switching Therapies in MS: What Are the Options?

Clyde E. Markowitz, MD

Activity | Posttest | Credits: 0.50 | Expires: 12/31/2017 | Keywords: medical conditions, None, None, None

Breakthrough disease is common, even in patients with good adherence to their medications. Read this Neurology Report to learn ways to assess and manage adherence, monitor disease course through clinical and MRI measures, and make timely treatment adjustments in your patients with multiple sclerosis.

Clyde E. Markowitz

Neurology Reports

Identifying and Addressing Unmet Therapeutic Needs in MS

Clyde E. Markowitz, MD

Activity | Posttest | Credits: 0.50 | Expires: 12/31/2017 | Keywords: medical conditions, None, None, None

Current disease-modifying treatments in multiple sclerosis (MS) are effectively mainly in relapsing forms of MS and do not restore function. Read this Neurology Report to discover unmet needs for treatments of progressive MS and MS symptoms and to learn about the development of neuroprotective agents.

+Improving Depression Outcomes by Providing Safe and Effective Care in the Rural Setting [Series Home Page]

J. Sloan Manning and W. Clay Jackson

Psychlopedia

Treating Depression in Primary Care: Initial and Follow-Up Treatment Strategies

J. Sloan Manning, MD, and W. Clay Jackson, MD, DipTh

Activity | Posttest | Credits: 0.50 | Expires: 12/31/2017 | Keywords: depression, None, None, None

What follow-up strategies do you use to help your patients with depression who don’t respond adequately to initial treatment? Here, get guidance on how to choose appropriate first-line treatment, and learn how to monitor patients and make timely treatment adjustments.

J. Sloan Manning and W. Clay Jackson

Psychlopedia

Providing Guideline-Concordant Assessment and Monitoring for Major Depression in Primary Care

J. Sloan Manning, MD, and W. Clay Jackson, MD, DipTh

Activity | Posttest | Credits: 0.50 | Expires: 12/31/2017 | Keywords: depression, None, None, None

How do you screen patients for depression in a busy primary care setting? In this new activity, read about effective assessment tools and strategies to diagnose depression and how to set goals and monitor progress once patients begin treatment.

+Depression: Addressing Partial Response After First-Line Antidepressant Treatment [Series Home Page]

Thase et al

JCP CME

Depression: Addressing Partial Response After First-Line Antidepressant Treatment

Michael E. Thase, MD (Chair), et al

Activity | Posttest | Credits: 0.50 | Expires: 9/30/2017 | Keywords: depression, None, None, None

How do you assess and treat residual symptoms in your patients who experience partial response to antidepressant therapy? Explore this Commentary to read a summary of 3 activities that provide assessment tools and treatment strategies for partial response and to learn areas of unmet needs and future education in depression treatment.

+Controversies in the Psychopharmacology of Bipolar Disorder [Series Home Page]

Robert M. Post, et al

Psychlopedia

Controversies in the Psychopharmacology of Bipolar Disorder

Robert M. Post, MD (Chair), et al

Activity | Posttest | Credits: 1.00 | Expires: 8/31/2017 | Keywords: bipolar disorder, None, None, None

What decision-making process do you use for selecting treatment for your patients with bipolar disorder? In this activity, review pharmacologic principles for the use of mood stabilizers, antipsychotics, and antidepressants, and find out how to choose appropriate therapies for maintenance treatment and partial response.

+Poster Sessions From The 2014 ASCP Annual Meeting [Series Home Page]

+Appropriate Management of Multiple Sclerosis in Primary Care [Series Home Page]

Levin and Jackson

Neurology Reports

Developing a Therapeutic Plan for MS: Evidence for New Treatments

Michael C. Levin, MD, and W. Clay Jackson, MD, DipTh

Activity | Posttest | Credits: 0.50 | Expires: 7/31/2017 | Keywords: medical conditions, None, None, None

Do you tailor your treatment plan for patients with MS according to their disease course and preferred administration method? Read this new Neurology Report to review the benefits and adverse effects of the available disease-modifying agents for MS and to select appropriate relapse treatment.

Levin and Jackson

Neurology Reports

Diagnosing MS: Recognizing Common Symptoms and Interpreting MRI Results

Michael C. Levin, MD, and W. Clay Jackson, MD, DipTh

Activity | Posttest | Credits: 0.50 | Expires: 6/30/2017 | Keywords: medical conditions, None, None, None

Early diagnosis of MS is critical for patients to begin disease-modifying therapy as soon as possible. Read this new Neurology Report to learn how to apply updated diagnostic criteria to recognize MS in its early stages and to rule out conditions similar to MS using appropriate tests.

+Update on Best Practices for Managing Bipolar Depression [Series Home Page]

+Measurement-Based Strategies to Assess and Manage Schizophrenia    [Series Home Page]

+Benefits and Barriers to Using Long-Acting Injectable Antipsychotics in Schizophrenia [Series Home Page]

+Improving the Diagnosis and Management of Depression in Bipolar Disorder [Series Home Page]

+Improving the Differential Diagnosis and Treatment of Bipolar Depression in Primary Care [Series Home Page]

+Update on Treatment-Resistant Depression: Translating Clinical Science Into Effective Therapies [Series Home Page]

+Restless Legs Syndrome: Recognition, Diagnosis, and Treatment of a Common Sleep Disorder [Series Home Page]

+Biological Therapies in Psychiatry [Series Home Page]

+Treatment of Depression in Primary Care: Using Tools to Improve Outcomes [Series Home Page]

+Depression: Managing the Full Range of Symptoms to Achieve Lasting Remission [Series Home Page]

+Working Together to Restore Mental Well-Being and Address Domestic Violence Among Veterans: A Call To Action [Series Home Page]

+Complicated OCD: Issues of Comorbidity and Clinical Challenges [Series Home Page]

+Understanding the Sleep-Wake Cycle: Sleep, Insomnia, and the Orexin System [Series Home Page]

+Assessing and Managing Pain and Major Depression With Medical Comorbidities [Series Home Page]

+NCDEU Poster Session 2013 [Series Home Page]

+Schizophrenia: Using Long-Acting Injectable Antipsychotics to Improve Treatment Adherence [Series Home Page]

+The Effects of the Affordable Care Act on the Practice of Psychiatry [Series Home Page]

+ADHD in College, Phase II: Managing the Risk of Misuse, Abuse, and Diversion [Series Home Page]

+Caring for Returning Veterans: Meeting Mental Health Needs [Series Home Page]

+Alzheimer's Disease: The Importance of Early Diagnosis and Appropriate Management [Series Home Page]

+Military- and Sports-Related Mild Traumatic Brain Injury: Clinical Presentation, Management, and Long-Term Consequences [Series Home Page]

+Expired Other [Series Home Page]

+Negative Symptoms in Schizophrenia: Treatment Gaps and Unmet Needs [Series Home Page]

+The Effect of Marijuana Use on the Risk for Schizophrenia [Series Home Page]

+Depression, Pain, and Comorbid Medical Conditions [Series Home Page]

+Improving Outcomes in Multiple Sclerosis Through Early Diagnosis and Effective Management [Series Home Page]

+A Fresh Look at Monoamine Oxidase Inhibitors for Depression [Series Home Page]

+NCDEU Poster Session 2012 [Series Home Page]

+The Appropriate Use of Opiates in Chronic Pain [Series Home Page]

+Multiple Sclerosis Syndromes and Symptoms: A Clinical Primer [Series Home Page]

+New Treatment Approaches for Major Depressive Disorder   [Series Home Page]

+Bipolar Disorder: Lessons for Rural Physicians: Adjunctive Interventions for Maintaining Remission [Series Home Page]

+Schizophrenia: When First-Line Treatment Fails [Series Home Page]

+ADHD in College: Seeking and Receiving Care During the Transition From Child to Adult [Series Home Page]

+Diagnosing and Managing Patients With Dementia [Series Home Page]

+Overview of Current Issues in the Management of Multiple Sclerosis [Series Home Page]

+International Consensus Group on Depression Prevention in Bipolar Disorder [Series Home Page]

+Alzheimer's Disease: Implications of the Updated Diagnostic and Research Criteria [Series Home Page]

+Fibromyalgia: Creating a Patient-Centered Diagnostic and Therapeutic Roadmap [Series Home Page]

+NCDEU Poster Session 2011 [Series Home Page]

+2011 ICBD Conference Coverage: Practical Applications of New Research in Bipolar Disorder [Series Home Page]

+Evidence for Using L-Methylfolate Combined With Antidepressants in MDD [Series Home Page]

+Depression: When Initial Therapy Fails [Series Home Page]

+Using Diagnostic and Assessment Tools for Adolescents With ADHD [Series Home Page]

+Using Moderator-Based Algorithms  and Electronic Medical Records  to Achieve Optimal Outcomes in Depression [Series Home Page]

+Expired Performance Improvement CME [Series Home Page]

+The Current Crisis of Confidence in Antidepressants [Series Home Page]

+New Approaches to Managing Schizoaffective Disorder From Diagnosis to Treatment [Series Home Page]

+NCDEU Poster Session 2010 [Series Home Page]

+Looking Past First-Line Therapy for Major Depressive Disorder [Series Home Page]

+Considerations in Managing Schizophrenia in Adolescents [Series Home Page]

+Challenges in the Long-Term Treatment of Schizophrenia [Series Home Page]

+Self-Assessment [Series Home Page]

+Improving Outcomes in Bipolar Disorder: From Early Recognition and Treatment to Remission [Series Home Page]

+Strategies for Selecting Treatment and Mitigating Risk in Patients With Chronic Pain [Series Home Page]

+Strategies for the Long-Term Treatment of Bipolar Disorder in Children and Adults [Series Home Page]

+Improving the Recognition and Treatment of Bipolar Disorder in Primary Care [Series Home Page]

+Improving Executive Function in Adults With ADHD [Series Home Page]

+Improving Outcomes in Depression [Series Home Page]

+International Consensus Group on Depression [Series Home Page]

+Debates and Directions in Fibromyalgia: Recognizing Signs and Selecting the Appropriate Paths [Series Home Page]

+Tackling Partial Remission to Depression Treatment [Series Home Page]

+The Use of Complementary and Alternative Medicines to Achieve Remission in Major Depressive Disorder [Series Home Page]

+NCDEU Poster Session 2009 [Series Home Page]

+What Is Bipolar Disorder? [Series Home Page]

+An Introduction to the Clinical Correlates of Disrupted Slow-Wave Sleep [Series Home Page]

+Following Up on The Expert Consensus Guidelines for Geriatric Depression [Series Home Page]

+Depression in Latinos: A Focus on Overcoming Barriers [Series Home Page]

+Bipolar Disorder in Children and Adolescents [Series Home Page]

+Definition and Management of Suicidality in Psychiatric Patients [Series Home Page]

+Balancing the Equation: Managing Medical Comorbidities in Patients With Severe Mental Illness [Series Home Page]

+Expired Case & Comment [Series Home Page]

+Maintenance of Certification in Psychiatry [Series Home Page]

+Bipolar Depression [Series Home Page]

+What Is Depression? [Series Home Page]

+Pain and the Brain 2: The Recognition and Management of Chronic Pain in Primary Care [Series Home Page]

+MDD in Women: Focus on Reproductive Events [Series Home Page]

+Using Atypical Antipsychotics to Optimize the Clinical Management of Patients With Mental Illnesses [Series Home Page]

+Depression in the Elderly [Series Home Page]

+Insights Into Generalized Anxiety Disorder [Series Home Page]

+Preventing Clinical Deterioration in the Course of Schizophrenia: The Potential for Neuroprotection [Series Home Page]

+ADHD and Comorbid Disorders in Adults [Series Home Page]

+Major Depressive Disorder [Series Home Page]

+Easing the Burden of Treatment-Resistant Depression [Series Home Page]

+Conference Coverage: 21st Annual European College of Neuropsychopharmacology (ECNP) Congress [Series Home Page]

+Depression and Pain [Series Home Page]

+Depression, Pain, and Physical Symptoms [Series Home Page]

+Easing the Burden of Bipolar Disorder: From Urgent Situations to Remission [Series Home Page]

+Poster Session: NCDEU 2008 [Series Home Page]

+Understanding Fibromyalgia and Its Related Disorders [Series Home Page]

+Translating the Psychopharmacology of Antipsychotics to Individualized Treatment for Severe Mental Illness: A Roadmap [Series Home Page]

+Clinical Insights Into Pharmacogenetics and Schizophrenia [Series Home Page]

+Pain and the Brain [Series Home Page]

+The Use of Atypical Antipsychotics in Pediatric Psychiatric Disorders [Series Home Page]

+Influencers of Treatment Success in Schizophrenia and Bipolar Disorder [Series Home Page]

+Maximizing Efficacy of Antidepressants Beyond Selective Serotonin Reuptake Inhibitors [Series Home Page]

+Conference Coverage: 20th European College of Neuropsychopharmacology (ECNP) Congress [Series Home Page]

+Smoking Cessation in Patients With Psychiatric Disorders [Series Home Page]

+A Longitudinal Study of Medication Nonadherence and Hospitalization Risk in Schizophrenia [Series Home Page]

+Raising the Bar in Schizophrenia by Treating to Remission [Series Home Page]

+Diagnosis and Treatment Strategies for Mixed Episodes in Bipolar Disorder [Series Home Page]

+Presentations From the Seventh International Conference on Bipolar Disorder [Series Home Page]

+Narcolepsy and Excessive Daytime Sleepiness: From the Bench to the Bedside [Series Home Page]

+Atypical Depression: Management Challenges and New Treatment Advances [Series Home Page]

+Cognitive Impairment Associated With Depression in the Elderly [Series Home Page]

+Managing Bipolar Disorder From Urgent Situations to Maintenance Therapy [Series Home Page]

+Weighing the Evidence: Weight Management Insights for Treating Major Mental Illness [Series Home Page]

+ADHD and Comorbid Substance Use Disorder [Series Home Page]

+Mixed Depression in Bipolar Disorders: Diagnosis and Treatment Strategies [Series Home Page]

+The Role of Folate in Depression and Dementia [Series Home Page]

+Strategies to Integrate Physical Health Care Into Mental Health [Series Home Page]

+Poster Session: NCDEU 2007 [Series Home Page]

+Special Issues Related to the Management of Bipolar Disorder in Women: Tolerability of Treatment [Series Home Page]

+Translating Evidence on Depression and Physical Symptoms into Effective Clinical Practice [Series Home Page]

+Distance Rounds [Series Home Page]

+Monoamine Oxidase Inhibitors Revisited: Their Role in Depressive Disorders [Series Home Page]

+The Art and Science of Switching Antipsychotic Medications [Series Home Page]

+Short-Term Naturalistic Treatment Outcomes in Cigarette Smokers With Substance Abuse and/or Mental Illness [Series Home Page]

+Preventing Recurrent Depression: Long-Term Treatment for Major Depressive Disorder [Series Home Page]

+Understanding Neuronal Pathways: Novel Targets for the Management of Insomnia [Series Home Page]

+Exercise for Mood and Anxiety Disorders [Series Home Page]

+Managing ADHD in Children, Adolescents, and Adults With Comorbid Anxiety [Series Home Page]

+Impact of Bipolar Disorder: Results From a Screening Study [Series Home Page]

+Transcranial Magnetic Stimulation: Potential New Treatment for Resistant Depression [Series Home Page]

+Evaluating the Evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and Beyond [Series Home Page]

+Practical Applications of Recent Antipsychotic Effectiveness Data [Series Home Page]

+Pathological Gambling: A Review of Phenomenological Models and Treatment Modalities for an Underrecognized Psychiatric Disorder [Series Home Page]

+ADHD: Applying Practice Guidelines to Improve Patient Outcome and Executive Function [Series Home Page]

+Practical Pharmacotherapeutic Management Strategies for Patients With Alcohol Dependence [Series Home Page]

+The Evolving View on Delta Sleep and Its Relationship to Daytime Function: A CME-Certified Virtual Symposium [Series Home Page]

+New Developments in Addiction Treatment [Series Home Page]

+Psychiatry in Brief: Insomnia and Emerging Therapies: Treating the Whole Patient [Series Home Page]

+Improving Cognitive Function and Functional Outcome in Severe Mental Illness [Series Home Page]

+Social Anxiety Disorder: Diagnosis, Outcome, Mechanisms, and Management [Series Home Page]

+Recent Advances in the Treatment of Depression in the Presence of Physical Symptoms [Series Home Page]

+Managing Patients With Vascular Disease and Depression [Series Home Page]

+Use of Treatment Algorithms for Depression [Series Home Page]

+Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD): A Clinical View [Series Home Page]

+New Developments in the Treatment of Attention-Deficit/Hyperactivity Disorder [Series Home Page]

+Bipolar Reports [Series Home Page]

+Antecedents to Panic Disorder in Nonreferred Adults [Series Home Page]

+The Challenges of Dual Diagnosis: Managing Substance Abuse in Severe Mental Illness [Series Home Page]

+A Systematic Review of Assessment and Treatment of Moderate to Severe Alzheimer's Disease [Series Home Page]

+Emerging Therapies for Bipolar Depression [Series Home Page]

+The Role of Dopamine and Norepinephrine in Depression and Antidepressant Treatment [Series Home Page]

+Agitated "Unipolar" Major Depression: Prevalence, Phenomenology, and Outcome [Series Home Page]

+Managing Nonadherence in Schizophrenia: The Role of Long-Acting Agents [Series Home Page]

+Distance Rounds [Series Home Page]

+Identifying and Managing Depression in the Medical Patient [Series Home Page]

+Atypical Antipsychotics in the Treatment of Mania: A Meta-Analysis of Randomized, Placebo-Controlled Trials [Series Home Page]

+Review of the Pharmacologic Management of Depression [Series Home Page]

+The Alzheimer's Disease Continuum: From Neuropathology to Clinical Practice [Series Home Page]

+The Impact of Disasters and Their Aftermath on Mental Health [Series Home Page]

+After the Tsunami: Mental Health Challenges to the Community for Today and Tomorrow [Series Home Page]

+Sleep: New Frontiers in Psychiatry and Primary Care [Series Home Page]

+The Recognition and Management of Bipolar Disorder With Comorbid Anxiety [Series Home Page]

+Focus on Bipolar Disorder Treatment [Series Home Page]

+Management of Autism and Its Related Disorders [Series Home Page]

+Sleep: New Frontiers in Psychiatry and Primary Care [Series Home Page]

+New Therapies for Treatment-Resistant Depression and Anxiety [Series Home Page]

+Safety Issues With Drug Therapies for Autism Spectrum Disorders [Series Home Page]

+Poster Session: July 2005 [Series Home Page]

+New Insights Into the Nature and Treatment of Panic Disorder [Series Home Page]

+The Role of Atypical Antipsychotics in the Treatment of Bipolar Disorder [Series Home Page]

+Utilizing Benzodiazepines in Clinical Practice: An Evidence-Based Discussion [Series Home Page]

+New Perspectives in Treating Bipolar Disorder [Series Home Page]

+The Need for Better Management of Treatment-Resistant Depression [Series Home Page]

+Differential Diagnosis and Management of Daytime Sleepiness and Nighttime Wakefulness [Series Home Page]

+Beyond Refractory Obsessions and Anxiety States: Toward Remission [Series Home Page]

+New Perspectives for Treating Generalized Anxiety Disorder [Series Home Page]

+Recognizing the Physical Symptoms of Depression [Series Home Page]

+Clinical Effectiveness of Atypical Antipsychotics in Dementia [Series Home Page]

+Managing Bipolar Depression [Series Home Page]

+Drug-Induced Movement Disorders [Series Home Page]

+Using Atypical Antipsychotics in Primary Care [Series Home Page]

+Revisiting the Use of High-Potency Benzodiazepines [Series Home Page]

+Diagnosing and Treating Attention-Deficit/Hyperactivity Disorder in Adults [Series Home Page]

+New Treatments for Depression Characterized by Physical Symptoms [Series Home Page]

+The Expert Consensus Guideline Series: Using Antipsychotic Agents in Older Patients [Series Home Page]

+Treating Aggressive Behavior in the Elderly [Series Home Page]

+Treating Depression: New Choices for a Chronic Problem [Series Home Page]

+Partial Compliance: The Need for Long-Acting Atypical Antipsychotics [Series Home Page]

+Optimizing Wakefulness in Patients With Fatigue and Executive Dysfunction [Series Home Page]

+The Expert Consensus Guideline Series: Optimizing Pharmacologic Treatment of Psychotic Disorders [Series Home Page]

+Long-Term Safety of Methylphenidate in the Treatment of ADHD: Dispelling the Myths and Misconceptions About Stimulant Therapy Abuse [Series Home Page]

+Noncholinergic Treatments for Alzheimer’s Disease [Series Home Page]

+Using the Newer Pharmacotherapeutic Agents as Mood Stabilizers in Bipolar Spectrum Disorders [Series Home Page]

+Physical Symptoms of Depression and Their Impact on Patients and Society [Series Home Page]

+Achieving Success in the Management of Bipolar Disorder: Is Lithium Sufficient? [Series Home Page]

+Management of Aggression Across the Life Cycle [Series Home Page]

+The Role of GABA in Neuropsychiatric Disorders: A Review of GABA Agents [Series Home Page]

+Treating Depression and Anxiety to Remission: Use of Algorithms [Series Home Page]

+New Approaches to Managing Difficult-to-Treat Depressions [Series Home Page]

+Anxiety: New Treatment Perspectives [Series Home Page]